Optical properties of hematoporphyrin monomethyl ether (HMME), a PDT photosensitizer

Photodiagnosis and Photodynamic Therapy

Volumn 9, Issue 3, 2012, Pages 232-242

  Lei, Tim C ^a   Glazner, Gregory F ^a   Duffy, Michael ^a   Scherrer, Larry ^a   Pendyala, Srinivas ^a   Li, Buhong ^b   Wang, Xiuli ^c   Wang, Hongwei ^c   Huang, Zheng ^b,d,e  

^a The University of Colorado Denver   (United States)

^b FUJIAN NORMAL UNIVERSITY   (China)

^c Shanghai Skin Disease Hospital   (China)

^d UNIVERSITY OF COLORADO   (United States)

^e DEPARTMENT OF MEDICINE   (United States)

Author keywords

Fluorescence; Hemoporfin ; HMME; Optical property; Photobleaching; Photodynamic therapy; Photosensitizer

Indexed keywords

HEMATOPORPHYRIN MONOMETHYL ETHER; HEMOPORFIN; PHOTOSENSITIZING AGENT; UNCLASSIFIED DRUG;

ARTICLE; BLEACHING; DOSIMETRY; FLUORESCENCE SPECTROSCOPY; LIGHT ABSORPTION; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; QUANTUM YIELD; TREATMENT OUTCOME; TREATMENT PLANNING;

FLUORESCENCE; HEMATOPORPHYRINS; LIGHT; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS; RADIATION DOSAGE; TEMPERATURE;

EID: 84865965004     PISSN: 15721000     EISSN: 18731597     Source Type: Journal    
DOI: 10.1016/j.pdpdt.2012.01.003     Document Type: Article

References (33)

1. Huang Z. Photodynamic therapy in China: over 25 years of unique clinical experience. Part One. History and domestic photosensitizers. Photodiagnosis Photodyn Ther 2006, 3:3-10.
2. Xu D. Research and development of photodynamic therapy photosensitizers in China. Photodiagnosis Photodyn Ther 2007, 4:13-25.
3. Li B.H., Lin L.S., Lin H.Y., Xie S.S. Singlet oxygen quantum yields of porphyrin-based photosensitizers for photodynamic therapy. J Innov Opt Health Sci 2008, 1:141-149.
4. Huang Z. Photodynamic therapy in China: over 25 years of unique clinical experience. Part Two. History and domestic photosensitizers. Photodiagnosis Photodyn Ther 2006, 3:71-84.
5. Yuan K.H., Li Q., Yu W.L., Zeng D., Zhang C., Huang Z. Comparison of photodynamic therapy and pulsed dye laser in patients with port wine stain birthmarks: a retrospective analysis. Photodiagnosis Photodyn Ther 2008, 5:50-57.
6. Huang Z. An update on the regulatory status of PDT photosensitizers in China. Photodiagnosis Photodyn Ther 2008, 5:285-287.
7. Fan S.J., Gu Y., Qiu H.X., Zeng J., Huang H.B. Effects of photodynamic therapy using hematoporphyrin monomethyl ether on experimental choroidal neovascularization. Chin J Laser Med Surg 2008, 17:80-85. [in Chinese].
8. Song K., Kong B., Li L., Yang Q., Wei Y., Qu X. Intraperitoneal photodynamic therapy for an ovarian cancer ascite model in Fischer 344 rat using hematoporphyrin monomethyl ether. Cancer Sci 2007, 98:1959-1964.
9. Yin H., Li Y., Zou Z., Qiao W., Yao X., Su Y., et al. Inactivation of bovine immunodeficiency virus by photodynamic therapy with HMME. Chin Opt Lett 2008, 6:944-946. [in Chinese].
10. Zou Z., Gao P., Yin H., Li Y.Y. Investigation of photodynamic therapy streptococcus mutants of oral biofilm. Chin Opt Lett 2008, 6:947-949. [in Chinese].
11. Colyer R.A., Lee C., Gratton E. A novel fluorescence lifetime imaging system that optimizes photon efficiency. Microsc Res Tech 2008, 71:201-203.
12. Digman M.A., Caiolfa V.R., Zamai M., Gratton E. The phasor approach to fluorescence lifetime imaging analysis. Biophys J 2008, 84:L14-L16.
13. Karoti A., Khurana M., Lepock J., Wilson B. Simultaneous two-photon excitation of Photofrin in relation to photodynamic therapy. Photochem Photobiol 2006, 82:443-452.
14. Makarov N., Drobizhev M., Rebane A. Two-photon absorption standards in the 550-1600nm excitation range. Optics Express 2008, 16:4029-4047.
15. Two Photon Cross Section Spectral Data Set, Developmental Resource for Biophysical Imaging Optoelectronics, Department of Bioengineering, Cornell University. http://www.drbio.cornell.edu/cross_sections.html.
16. Li B.H., Xie S.S., Lu Z.K. Spectral properties of new photosensitizers for photodynamic diagnosis and therapy. Guang Pu Xue Yu Guang Pu Fen Xi (Spectrosc Spectral Anal) 2002, 22:902-904. [in Chinese].
17. Andreoni A., Cubeddu R. Photophysical properties of Photofrin II in different solvents. Chem Phys Lett 1984, 108:141-144.
18. Pu Y., Chen W., Yu Z. Research progress of Hemoporfin - Part one. Preclinical study. Photodiagnosis Photodyn Ther 2012, 9(2):180-185.
19. Zhou G.Y., Zhang Z.Y., Gu J.Z., Ma J.Z. Comparative research on mixed and 488nm argon laser PDT for Port Wine Stain. Shanghai J Stomatol 2000, 9:173-174. [in Chinese].
20. Zhou G.Y., Zhang Z.Y. Preliminary clinical study on Krypton laser photodynamic therapy for PWS. Shanghai J Stomatol 2000, 9:168-170. [in Chinese].
21. Huang Z. A review of progress in clinical photodynamic therapy. Technol Cancer Res Treat 2005, 4:283-293.
22. Li B.H., Lu Z.K., Xie S.S. Time-resolved fluorescence studies of for photodynamic diagnosis. Guang Pu Xue Yu Guang Pu Fen Xi (Spectrosc Spectral Anal) 2003, 23:331-333. [in Chinese].
23. Bottiroli G., Freitas I., Docchio F., Ramoni R., Sacchi C. The time-dependent behavior of hematoporphyrin-derivative in saline: a study of spectral modifications. Chem Biol Interactions 1984, 49:1-11.
24. Stringer M., Moghissi K. Photodiagnosis and fluorescence imaging in clinical practice. Photodiagnosis Photodyn Ther 2004, 1:9-12.
25. Spikes J.D. Quantum yields and kinetics of the photobleaching of hematoporphyrin Photofrin II, tetra(4-sulfonatophenyl) porphine and uroporphyrin. Photochem Photobiol 1992, 55:797-808.
26. Robinson D.J., de Bruijn H.S., van der Veen N., Stringer M.R., Brown S.B., Star W.M. Fluorescence photobleaching of ALA-induced protoporphyrin IX during photodynamic therapy of normal hairless mouse skin: the effect of light dose and irradiance and the resulting biological effect. Photochem Photobiol 1998, 67:140-149.
27. Dysart J.S., Singh G., Patterson M.S. Calculation of singlet oxygen dose from photosensitizer fluorescence emission and photobleaching during mTHPC photodynamic therapy of MLL cells. Photochem Photobiol 2005, 81:196-205.
28. Warren C.B., Lohser S., Wene L.C., Pogue B.W., Bailin P.L., Maytin E.V. Noninvasive fluorescence monitoring of protoporphyrin IX production and clinical outcomes in actinic keratoses following short-contact application of 5-aminolevulinate. J Biomed Opt 2010, 15:051607.
29. Zeng H., Korbelik M., McLean D.I., MacAulay C., Lui H. Monitoring photoproduct formation and photobleaching by fluorescence spectroscopy has the potential to improve PDT dosimetry with a verteporfin-like photosensitizer. Photochem Photobiol 2002, 75:398-405.
30. Wang L., Gu Y., Li F.S., Liu F.G., Yu C.Q. Fluorescence spectroscopy study of photobleaching properties of photosensitizers in photodynamic therapy. Guang Pu Xue Yu Guang Pu Fen Xi (Spectrosc Spectral Anal) 2007, 27:2073-2078. [in Chinese].
31. Glazner G.F., Lei T., Duffy M., Scherrer L., Pendyala S., Wang X.L., et al. Preliminary study of optical properties of hematoporphyrin monomethyl ether (HMME), a new PDT sensitizer. Proc SPIE 2009, 7551. 75510P-75510P-7.
32. Samkoe K.S., Clancy A.A., Karotki A., Wilson B.C., Cramb D.T. Complete blood vessel occlusion in the chick chorioallantoic membrane using two-photon excitation photodynamic therapy: implications for treatment of wet age-related macular degeneration. J Biomed Opt 2007, 12:034025.
33. Dahlstedt E., Collins H.A., Balaz M., Kuimova M.K., Khurana M., Wilson B.C., et al. One- and two-photon activated phototoxicity of conjugated porphyrin dimers with high two-photon absorption cross sections. Org Biomol Chem 2009, 7:897-904.